The Boston Guide to Ketamine and Psychedelic Therapy

The Ketamine and Psychedelic Therapy Options in Boston, Briefly

If you are trying to work out how to get ketamine care or find a psychedelic therapist in Boston, there are a handful of genuine paths, and they differ in where treatment happens, what it costs, and who qualifies. Here is each one, neutrally, before we get into which might fit you. This is a guide to real ketamine therapy providers and options in Boston and across Massachusetts, not a single pitch.

A note for anyone searching for a psychedelic therapist or psychedelics therapy near me: many people mean psilocybin, MDMA, LSD, or ayahuasca. None of those are legally available for therapy in Massachusetts today, and MDMA-assisted therapy is not FDA-approved. That is why, for people who want a psychedelic-class treatment they can actually begin now, ketamine is the practical answer, and it is available both in clinics and at home.

Which Option Fits You

A quick way to narrow it down, without ranking any option above another:

• If your insurance covers Spravato and you prefer a monitored, in-office nasal-spray treatment, a certified Spravato center in Boston may be the fit.
• If the ~100% bioavailability of IV ketamine is improtant and/or you prefer on-site clinical staff, an in-clinic ketamine provider in Boston or Cambridge is worth a call.
• If you are drawn to psilocybin or MDMA therapy, a clinical trial or an out-of-state licensed program is the current route.
• If you want treatment from home in Boston on a clinician-guided schedule, at-home ketamine therapy with Mindbloom is built for that.

Ketamine and Psychedelic Therapy Availability Across Greater Boston

Where you live in Greater Boston shapes your in-person options more than your at-home ones. In-clinic ketamine and Spravato providers concentrate in Boston and Cambridge, while at-home ketamine therapy reaches every community in the metro through telehealth.

That means ketamine therapy in Cambridge, Somerville, Newton, Brookline, and Quincy, along with North Shore communities like Beverly and Salem and MetroWest towns like Framingham and Waltham, is available from home for eligible adults, with the same clinician-guided program wherever you are. If you would rather be treated in person, the nearest in-clinic ketamine providers cluster in Boston and Cambridge.

Is Ketamine or Psychedelic Therapy Legal in Boston and Massachusetts?

Ketamine is legal. It is an FDA Schedule III medication that a licensed clinician can prescribe, and it is available now in Massachusetts, in clinics and at home via telehealth. For mental health, ketamine is prescribed off-label, and a clinician confirms eligibility before treatment begins. So the answer to is ketamine legal in Massachusetts is yes, for eligible adults under clinician care.

Broader psychedelic therapy is not. On the question of whether psilocybin is legal in Massachusetts, the answer is no. Massachusetts voters rejected Question 4, the natural-psychedelics legalization measure, in November 2024, so psilocybin remains a Schedule I substance statewide.¹⁰ Somerville became the first Massachusetts community to deprioritize entheogens in January 2021, and Cambridge followed weeks later, but these are local enforcement-priority resolutions, not legalization, and Boston proper has not passed one.¹¹ MDMA-assisted therapy is not FDA-approved, and ayahuasca and LSD are not legal therapy options here either.

There is movement worth watching. As of this writing in August 2026, the Massachusetts House has passed a five-year psychedelic-therapy pilot program that would let a small number of licensed clinics offer supervised psychedelic treatment, but it still needs Senate passage and Governor Healey's signature and is not yet law.¹² Until something like that takes effect, the psychedelic-class therapy you can legally begin in Boston today is ketamine, including from home with Mindbloom.

Why People Choose At-Home Care, and What the Outcomes Show

For people weighing the options above, at-home care tends to win on two things: access and evidence. Mindbloom has delivered more than 800,000 guided at-home sessions and is one of the largest at-home psychedelic-therapy providers. Its outcomes table below draws on a peer-reviewed subcutaneous study (Parks 2026) that covers depression, anxiety, and PTSD in a single study, alongside two earlier peer-reviewed studies of its sublingual protocol (Hull 2022, Mathai 2024) and research preprints extending the evidence to grief, burnout, and sleep, the largest published evidence base in at-home ketamine therapy. Mindbloom is also the only at-home ketamine therapy provider with peer-reviewed PTSD outcomes. If you are weighing in-clinic infusions, it is also worth understanding how at-home sublingual ketamine compares with IV.

_{¹ Subcutaneous, six-session course (Parks 2026). Response = at least 50% reduction (PHQ-9/GAD-7) or at least 10 points (PCL-5); remission = final PHQ-9/GAD-7 below 5, or at least a 10-point reduction and PCL-5 below 33. ² Grief (Swain 2026, PGD-13), n=503. ³ Burnout (Swain, MBI-GS), n=395. ⁴ Sleep (Swain 2026, PHQ-9 Item 3), n=13,963; single-item measure, and ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1% DSM-5-TR). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0). Individual results vary.}

These figures reflect Mindbloom's own client data, on its subcutaneous protocol. Mindbloom offers tailored psychedelic-therapy programs, built with mental-health thought leaders, that use the psychedelic modality to address specific outcomes rather than only prescribing medication for them. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

How those results compare to other treatments studied, using Mindbloom's reported rates against rates reported in specific studies:

• Mindbloom's reported depression response rate is roughly 38% higher than the rate reported in a study of psychotherapy for depression (56.6% vs about 41%), and reached faster.¹ ⁵
• Mindbloom's reported anxiety response rate is about 29% higher than the rate reported in a study of CBT for generalized anxiety (60.6% vs 47%), in about half the time.¹ ⁶
• Mindbloom's reported PTSD response rate is about 32% higher than the rate reported in a study of first-line SSRIs (76.7% vs 58%).¹ ⁷
• Mindbloom's reported depression response (56.6%) is at or above the rate reported in the largest controlled trials of single-dose psilocybin for depression (about 37 to 42%), on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.¹ ⁸

How At-Home Ketamine Therapy Works, and Who It Is For

At-home ketamine therapy with Mindbloom starts with an online clinical evaluation. A licensed clinician reviews your history and decides whether treatment is a good fit, and if approved, your program and treatment frequency are personalized with clinician-guided scheduling rather than a fixed cadence. Sessions happen at home with preparation, guided support, and integration built in, so the medicine sits inside a structured program rather than a standalone prescription.

It is designed for eligible adults, most commonly people seeking help with depression, and also anxiety, PTSD, grief, burnout, and sleep. Ketamine therapy can bring both relatively rapid initial relief and longer-term, cumulative benefit over a program. A clinician confirms candidacy, so it is not for everyone, and that evaluation is part of what makes it a genuine medical treatment rather than an on-demand product.

Cost and Insurance for Ketamine Therapy in Boston

On cost, the plain comparison is this. In-clinic IV ketamine in Boston runs roughly $475 to $650 or more per infusion, and Mass General lists $550 per infusion, out of pocket.¹³ ¹⁴ At-home ketamine therapy with Mindbloom is $165 to $215 per session within a program, and it is HSA and FSA eligible, with some clients pursuing out-of-network reimbursement.

If you are searching for ketamine therapy near me that takes insurance, here is the honest picture: in-clinic IV ketamine is generally paid out of pocket, and Spravato may be covered by insurance for people who qualify, subject to the insurer's prior authorization, otherwise it is out of pocket. Mindbloom is not billed to insurance, but its per-session pricing and HSA/FSA eligibility are what many people compare against in-clinic infusion costs. Eligibility begins with an online clinician evaluation.